Co-Diagnostics, Inc.

CODX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$5,887-$7,730-$7,533-$11,031
Dep. & Amort.$267$291$280$357
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$580$875$1,318
Change in WC-$783-$1,159-$1,318$1,729
Other Non-Cash$498-$271-$1,050-$604
Operating Cash Flow-$5,905-$8,288-$8,745-$8,231
Investing Activities
PP&E Inv.-$75-$401-$92-$73
Net Acquisitions$0$0$0$0
Inv. Purchases-$2-$144-$6,445-$13,395
Inv. Sales/Matur.$2,252$17,616$13,894$13,734
Other Inv. Act.$0$0$0$0
Investing Cash Flow$2,175$17,071$7,357$266
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$4,058$429$355$104
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$4,058$429$355$104
Forex Effect$0$0$0$0
Net Chg. in Cash$329$9,212-$1,034-$7,861
Supplemental Information
Beg. Cash$11,115$1,903$2,937$10,798
End Cash$11,444$11,115$1,903$2,937
Free Cash Flow-$5,980-$8,689-$8,837-$8,304
Co-Diagnostics, Inc. (CODX) Financial Statements & Key Stats | AlphaPilot